UPDATE: Regeneron Pharma (REGN) Easily Tops Q4 EPS Views; Guides FY14 EYLEA Sales
Tweet Send to a Friend
(Updated - February 11, 2014 6:53 AM EST)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $2.24, $1.27 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $2.24, $1.27 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
